AbbVie (ABBV) News Today $187.32 -8.75 (-4.46%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$188.48 +1.16 (+0.62%) As of 07:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period AbbVie Inc. (NYSE:ABBV) Shares Sold by Cambridge Investment Research Advisors Inc.Cambridge Investment Research Advisors Inc. cut its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 489,811 shares of the company's stock after sellingMay 7 at 7:25 AM | marketbeat.comCutter Capital Management LP Makes New $18.13 Million Investment in AbbVie Inc. (NYSE:ABBV)Cutter Capital Management LP purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 101,996 shares of the company's stock, valMay 7 at 7:25 AM | marketbeat.comCapitolis Liquid Global Markets LLC Has $115.51 Million Stake in AbbVie Inc. (NYSE:ABBV)Capitolis Liquid Global Markets LLC reduced its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 19.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 650,000 shares of the company's stoMay 7 at 7:13 AM | marketbeat.comAbbVie Q1 Earnings TranscriptMay 7 at 7:13 AM | marketbeat.comCetera Investment Advisers Grows Position in AbbVie Inc. (NYSE:ABBV)Cetera Investment Advisers grew its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 623,679 shares of the company's stock after acquiring an additional 10,254 shares durMay 7 at 6:51 AM | marketbeat.comCercano Management LLC Increases Stock Position in AbbVie Inc. (NYSE:ABBV)Cercano Management LLC increased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5,398.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 98,372 shares of the company's stock after purchasing an additional 96,583 shMay 7 at 6:50 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Brandywine Trust Co.Brandywine Trust Co. decreased its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 4.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 121,589 shares of the company's stock after selling 5,080 shares during the quarter. AbbVie accounts fMay 7 at 6:22 AM | marketbeat.comCahill Financial Advisors Inc. Invests $501,000 in AbbVie Inc. (NYSE:ABBV)Cahill Financial Advisors Inc. purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,819 shares of the company's stock, valued at approximately $501,000. Other hedge fMay 7 at 5:58 AM | marketbeat.comCaxton Associates LP Has $1.34 Million Stake in AbbVie Inc. (NYSE:ABBV)Caxton Associates LP reduced its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 47.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,566 shares of the company's stock after selling 6,788 shares during the perMay 7 at 5:47 AM | marketbeat.comAlyeska Investment Group L.P. Makes New $2.30 Million Investment in AbbVie Inc. (NYSE:ABBV)Alyeska Investment Group L.P. bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 12,957 shares of the company's stock, valued at approximately $2,302,000. SeverMay 7 at 4:51 AM | marketbeat.com3 Unexpected Winners From Trump’s TariffsMay 7 at 12:56 AM | wallstreetzen.comChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock RecommendationsMay 6 at 6:52 PM | msn.comAbbVie (NYSE:ABBV) Trading Down 1.3% - Here's WhyAbbVie (NYSE:ABBV) Trading Down 1.3% - Here's WhyMay 6 at 3:40 PM | marketbeat.comAbbVie (ABBV) Set for Gains with Medicare Policy Shift | ABBV Stock NewsMay 6 at 12:07 PM | gurufocus.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in ...May 6 at 12:07 PM | gurufocus.comAbbVie to Present at the Bank of America Securities Healthcare ConferenceMay 6 at 12:04 PM | gurufocus.comAbbVie to Present at the Bank of America Securities Healthcare ConferenceMay 6 at 8:00 AM | prnewswire.com1,670 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Blue Capital Inc.Blue Capital Inc. bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 1,670 shares of the company's stock, valued at approximately $297,000. Several otherMay 6 at 7:26 AM | marketbeat.comCaptrust Financial Advisors Buys 66,432 Shares of AbbVie Inc. (NYSE:ABBV)Captrust Financial Advisors raised its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 5.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 1,295,297 shares of the company's stock after buying an additional 66,432 shares during the period. CaptruMay 6 at 6:52 AM | marketbeat.comCary Street Partners Financial LLC Takes $21.86 Million Position in AbbVie Inc. (NYSE:ABBV)Cary Street Partners Financial LLC purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 123,013 shares of the company's stock, valued at approximately $21,859,000. AbbVMay 6 at 6:44 AM | marketbeat.comChapman Financial Group LLC Purchases New Holdings in AbbVie Inc. (NYSE:ABBV)Chapman Financial Group LLC acquired a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,900 shares of the company's stock, valued at approximately $515,000. Several other institutional iMay 6 at 6:28 AM | marketbeat.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit - ABBVMay 6 at 5:45 AM | prnewswire.comBLI Banque de Luxembourg Investments Buys New Position in AbbVie Inc. (NYSE:ABBV)BLI Banque de Luxembourg Investments acquired a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 12,999 shares of the company's stock, valued at approximaMay 6 at 5:32 AM | marketbeat.comBiotech Stocks To Add to Your Watchlist - May 4thAbbVie, Thermo Fisher Scientific, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that use biological processes, molecular biology and genetic engineering to develop medical therapies, diagMay 5 at 2:01 PM | marketbeat.comCerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights – ABBVMay 5 at 1:53 PM | globenewswire.comAvidity Partners Management LP Decreases Stake in AbbVie Inc. (NYSE:ABBV)Avidity Partners Management LP decreased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 19.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 80,700 shares of the company's stock after selling 19,300 shares during the period. Avidity Partners MMay 5 at 7:39 AM | marketbeat.comBrown Advisory Inc. Increases Holdings in AbbVie Inc. (NYSE:ABBV)Brown Advisory Inc. increased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 840,660 shares of the company's stock after purchasinMay 5 at 7:38 AM | marketbeat.comBaird Financial Group Inc. Sells 31,647 Shares of AbbVie Inc. (NYSE:ABBV)Baird Financial Group Inc. trimmed its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,080,595 shares of the company's stock after sellinMay 5 at 7:21 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Position Trimmed by Baker Avenue Asset Management LPBaker Avenue Asset Management LP trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 105,599 shares of the company's stock after selling 4,565 shares during the period. BMay 5 at 6:58 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Baldwin Investment Management LLCBaldwin Investment Management LLC trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 9.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,533 shares of the company's stock after selling 2,918 shares dMay 5 at 6:57 AM | marketbeat.comBellevue Group AG Boosts Stake in AbbVie Inc. (NYSE:ABBV)Bellevue Group AG boosted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 45,259 shares of the company's stock after purchasing an additional 2,373 shares duringMay 5 at 6:40 AM | marketbeat.comClass Action Filed Against Cerevel Therapeutics Holdings, Inc. ...May 5 at 6:40 AM | gurufocus.comBearing Point Capital LLC Acquires Shares of 16,054 AbbVie Inc. (NYSE:ABBV)Bearing Point Capital LLC acquired a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 16,054 shares of the company's stock, valued at approximately $2,853May 5 at 6:18 AM | marketbeat.comBenjamin Edwards Inc. Acquires 16,132 Shares of AbbVie Inc. (NYSE:ABBV)Benjamin Edwards Inc. increased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 352,098 shares of the company's stock after acquiring an additional 16,132 shares during the period. AbbVieMay 5 at 5:58 AM | marketbeat.comBNP Paribas Acquires 1,755 Shares of AbbVie Inc. (NYSE:ABBV)BNP Paribas lifted its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 47,815 shares of the company's stock after buying an additional 1,755 shares during the quarter. BNP PariMay 5 at 5:48 AM | marketbeat.comClass Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors - Contact The Gross Law FirmMay 5 at 5:45 AM | prnewswire.comAbbVie Inc. (NYSE:ABBV) Stock Holdings Decreased by Ameriprise Financial Inc.Ameriprise Financial Inc. decreased its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,030,668 shares of the company's stock after selling 809,440 shares during the period. AbbVieMay 5 at 5:41 AM | marketbeat.comBest Biotech Stocks To Research - May 3rdAbbVie, Thermo Fisher Scientific, Vertex Pharmaceuticals, Danaher, and Cognizant Technology Solutions are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies whose primary business involves researching, develoMay 4 at 2:02 PM | marketbeat.com6,846 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Alteri Wealth LLCAlteri Wealth LLC purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 6,846 shares of the company's stock, valued at approximately $1,217,00May 4 at 7:35 AM | marketbeat.comAmeriServ Wealth Advisors Acquires New Stake in AbbVie Inc. (NYSE:ABBV)AmeriServ Wealth Advisors purchased a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,882 shares of the company's stock, valued at approximately $334,000. SevMay 4 at 7:34 AM | marketbeat.comAncora Advisors LLC Has $62.31 Million Holdings in AbbVie Inc. (NYSE:ABBV)Ancora Advisors LLC reduced its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 0.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 350,638 shares of the company's stock after selling 2,328 shares during the period. AbbViMay 4 at 7:26 AM | marketbeat.comAptus Capital Advisors LLC Buys 29,972 Shares of AbbVie Inc. (NYSE:ABBV)Aptus Capital Advisors LLC boosted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 36.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 113,315 shares of the company's stock after purchasing an additional 29,9May 4 at 7:13 AM | marketbeat.comAristotle Capital Management LLC Reduces Position in AbbVie Inc. (NYSE:ABBV)Aristotle Capital Management LLC trimmed its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 66,615 shares of the company's stock after selling 2,040 shares during the quarter.May 4 at 7:01 AM | marketbeat.comAspire Growth Partners LLC Purchases Shares of 2,739 AbbVie Inc. (NYSE:ABBV)Aspire Growth Partners LLC acquired a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,739 shares of the company'sMay 4 at 6:39 AM | marketbeat.com151,752 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Ariel Investments LLCAriel Investments LLC acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 151,752 shares of the company's stock, valued at approxiMay 4 at 6:38 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Atalanta Sosnoff Capital LLCAtalanta Sosnoff Capital LLC decreased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 5.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 404,398 shares of the company's stock after selling 23May 4 at 6:23 AM | marketbeat.comAxa S.A. Has $172.71 Million Position in AbbVie Inc. (NYSE:ABBV)Axa S.A. increased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 14.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 971,893 shares of the company's stock after purchasing an additional 125,568May 4 at 6:22 AM | marketbeat.com7,293 Shares in AbbVie Inc. (NYSE:ABBV) Purchased by Advanced Portfolio Management LLCAdvanced Portfolio Management LLC purchased a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 7,293 shares of the companMay 4 at 6:14 AM | marketbeat.comAlTi Global Inc. Sells 6,590 Shares of AbbVie Inc. (NYSE:ABBV)AlTi Global Inc. decreased its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 9.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 61,945 shares of the company's stock after selling 6,590 shares during tMay 4 at 6:13 AM | marketbeat.comFreestone Grove Partners LP Makes New Investment in AbbVie Inc. (NYSE:ABBV)Freestone Grove Partners LP bought a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 7,601 shares of the company's stock, valued at approximateMay 4 at 5:28 AM | marketbeat.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼1.060.69▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼9251▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today CORT News Today JAZZ News Today PRGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy abbv Stock Free abbv Stock Alerts